Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 77094 | 61.115 |
09:34 ET | 82906 | 62.09 |
09:36 ET | 24771 | 61.53 |
09:38 ET | 23093 | 61.7155 |
09:39 ET | 6213 | 61.69 |
09:41 ET | 16307 | 61.8299 |
09:43 ET | 4828 | 61.7 |
09:45 ET | 13428 | 61.8 |
09:48 ET | 32582 | 61.899 |
09:50 ET | 15403 | 61.825 |
09:52 ET | 14407 | 61.89 |
09:54 ET | 11785 | 61.73 |
09:56 ET | 18822 | 61.48 |
09:57 ET | 20305 | 61.37 |
09:59 ET | 16568 | 61.285 |
10:01 ET | 17186 | 61.111 |
10:03 ET | 27468 | 61.22 |
10:06 ET | 12246 | 61.19 |
10:08 ET | 7375 | 61.24 |
10:10 ET | 10240 | 61.1377 |
10:12 ET | 29164 | 61.025 |
10:14 ET | 13642 | 61.13 |
10:15 ET | 13171 | 61.3 |
10:17 ET | 9816 | 61.48 |
10:19 ET | 9951 | 61.5 |
10:21 ET | 23544 | 61.36 |
10:24 ET | 14147 | 61.14 |
10:26 ET | 15132 | 61.18 |
10:28 ET | 5685 | 61.09 |
10:30 ET | 29273 | 61.0482 |
10:32 ET | 9147 | 61.005 |
10:33 ET | 12751 | 61.01 |
10:35 ET | 11146 | 61.215 |
10:37 ET | 8992 | 61.16 |
10:39 ET | 19302 | 61.18 |
10:42 ET | 2245 | 61.18 |
10:44 ET | 14841 | 61.235 |
10:46 ET | 11568 | 61.07 |
10:48 ET | 4530 | 61.1 |
10:50 ET | 9631 | 61.18 |
10:51 ET | 8010 | 61.29 |
10:53 ET | 5553 | 61.37 |
10:55 ET | 7510 | 61.37 |
10:57 ET | 4810 | 61.24 |
11:00 ET | 8750 | 61.26 |
11:02 ET | 5206 | 61.355 |
11:04 ET | 12798 | 61.26 |
11:06 ET | 14150 | 61.21 |
11:08 ET | 22136 | 61.28 |
11:09 ET | 36094 | 61.18 |
11:11 ET | 5905 | 61.165 |
11:13 ET | 15562 | 61.085 |
11:15 ET | 12775 | 61.08 |
11:18 ET | 4915 | 61.1 |
11:20 ET | 17523 | 60.95 |
11:22 ET | 20014 | 60.925 |
11:24 ET | 31518 | 60.805 |
11:26 ET | 22717 | 60.795 |
11:27 ET | 22811 | 60.6841 |
11:29 ET | 16042 | 60.7 |
11:31 ET | 22180 | 60.65 |
11:33 ET | 14421 | 60.66 |
11:36 ET | 11262 | 60.67 |
11:38 ET | 4099 | 60.6728 |
11:40 ET | 7546 | 60.65 |
11:42 ET | 25822 | 60.5543 |
11:44 ET | 18567 | 60.67 |
11:45 ET | 14050 | 60.5481 |
11:47 ET | 22312 | 60.555 |
11:49 ET | 15490 | 60.4604 |
11:51 ET | 16093 | 60.44 |
11:54 ET | 18668 | 60.44 |
11:56 ET | 13542 | 60.52 |
11:58 ET | 22237 | 60.5599 |
12:00 ET | 12859 | 60.52 |
12:02 ET | 13405 | 60.6 |
12:03 ET | 10821 | 60.68 |
12:05 ET | 7937 | 60.72 |
12:07 ET | 14904 | 60.68 |
12:09 ET | 10995 | 60.7 |
12:12 ET | 19836 | 60.675 |
12:14 ET | 18931 | 60.5501 |
12:16 ET | 18154 | 60.535 |
12:18 ET | 5484 | 60.545 |
12:20 ET | 9873 | 60.515 |
12:21 ET | 18338 | 60.528 |
12:23 ET | 13027 | 60.5181 |
12:25 ET | 21653 | 60.435 |
12:27 ET | 26900 | 60.345 |
12:30 ET | 30052 | 60.2744 |
12:32 ET | 27456 | 60.27 |
12:34 ET | 16009 | 60.33 |
12:36 ET | 16178 | 60.26 |
12:38 ET | 8879 | 60.28 |
12:39 ET | 16827 | 60.2601 |
12:41 ET | 41393 | 60.33 |
12:43 ET | 8126 | 60.32 |
12:45 ET | 12931 | 60.37 |
12:48 ET | 15950 | 60.41 |
12:50 ET | 10961 | 60.435 |
12:52 ET | 8781 | 60.48 |
12:54 ET | 14281 | 60.41 |
12:56 ET | 4670 | 60.4504 |
12:57 ET | 9034 | 60.365 |
12:59 ET | 12395 | 60.345 |
01:01 ET | 4182 | 60.37 |
01:03 ET | 36562 | 60.378 |
01:06 ET | 17276 | 60.335 |
01:08 ET | 26816 | 60.21 |
01:10 ET | 14502 | 60.29 |
01:12 ET | 7095 | 60.37 |
01:14 ET | 4757 | 60.37 |
01:15 ET | 5949 | 60.3444 |
01:17 ET | 11955 | 60.3 |
01:19 ET | 3319 | 60.28 |
01:21 ET | 7269 | 60.245 |
01:24 ET | 17099 | 60.215 |
01:26 ET | 26367 | 60.15 |
01:28 ET | 43181 | 60.12 |
01:30 ET | 41335 | 60.07 |
01:32 ET | 65179 | 60.025 |
01:33 ET | 18042 | 60.095 |
01:35 ET | 292570 | 59.95 |
01:37 ET | 38076 | 59.85 |
01:39 ET | 72010 | 59.7063 |
01:42 ET | 44981 | 59.975 |
01:44 ET | 33353 | 59.96 |
01:46 ET | 24162 | 59.92 |
01:48 ET | 14880 | 59.9548 |
01:50 ET | 7275 | 59.989 |
01:51 ET | 19551 | 59.855 |
01:53 ET | 16135 | 59.85 |
01:55 ET | 13860 | 59.8301 |
01:57 ET | 18814 | 59.799 |
02:00 ET | 9669 | 59.9184 |
02:02 ET | 13810 | 59.89 |
02:04 ET | 20893 | 59.87 |
02:06 ET | 20996 | 59.94 |
02:08 ET | 20557 | 59.965 |
02:09 ET | 18014 | 59.98 |
02:11 ET | 19314 | 59.985 |
02:13 ET | 11030 | 60 |
02:15 ET | 18775 | 60 |
02:18 ET | 4240 | 59.99 |
02:20 ET | 21363 | 59.995 |
02:22 ET | 26410 | 60 |
02:24 ET | 40726 | 60.04 |
02:26 ET | 38667 | 60.06 |
02:27 ET | 27143 | 60.02 |
02:29 ET | 12892 | 60.18 |
02:31 ET | 21554 | 60.1 |
02:33 ET | 8605 | 60.06 |
02:36 ET | 16817 | 60 |
02:38 ET | 42122 | 60.06 |
02:40 ET | 32779 | 60.01 |
02:42 ET | 23127 | 60.02 |
02:44 ET | 38218 | 60.02 |
02:45 ET | 18171 | 60 |
02:47 ET | 15371 | 60.02 |
02:49 ET | 4041 | 60.105 |
02:51 ET | 16725 | 60.07 |
02:54 ET | 3849 | 60.06 |
02:56 ET | 2688 | 60.1 |
02:58 ET | 10149 | 60.08 |
03:00 ET | 8085 | 60.1 |
03:02 ET | 15870 | 60.07 |
03:03 ET | 4686 | 60.095 |
03:05 ET | 6015 | 60.1 |
03:07 ET | 21199 | 60.095 |
03:09 ET | 20924 | 60.2274 |
03:12 ET | 10662 | 60.2448 |
03:14 ET | 5785 | 60.18 |
03:16 ET | 12280 | 60.15 |
03:18 ET | 16207 | 60.12807 |
03:20 ET | 19866 | 60.16 |
03:21 ET | 8254 | 60.15 |
03:23 ET | 47141 | 60.185 |
03:25 ET | 49957 | 60.195 |
03:27 ET | 31698 | 60.17 |
03:30 ET | 40704 | 60.2 |
03:32 ET | 42304 | 60.26 |
03:34 ET | 32134 | 60.2 |
03:36 ET | 66991 | 60.17 |
03:38 ET | 25133 | 60.13 |
03:39 ET | 40239 | 60.14 |
03:41 ET | 34476 | 60.130829 |
03:43 ET | 31538 | 60.15 |
03:45 ET | 44398 | 60.14 |
03:48 ET | 43552 | 60.32 |
03:50 ET | 48217 | 60.175 |
03:52 ET | 24435 | 60.4117 |
03:54 ET | 104135 | 60.155 |
03:56 ET | 52062 | 60.15 |
03:57 ET | 73175 | 60.15 |
03:59 ET | 559579 | 60.21 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 23.1B | -3.9x | --- |
ICON PLC | 24.3B | 34.1x | +4.68% |
Grifols SA | 7.2B | 36.7x | --- |
Biogen Inc | 27.0B | 23.4x | -18.14% |
Biontech SE | 29.2B | -53.4x | --- |
Incyte Corp | 13.0B | 190.8x | +39.11% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $23.1B |
---|---|
Revenue (TTM) | $5.1B |
Shares Outstanding | 384.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-15.37 |
Book Value | $36.27 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -91.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.